Viral Vector and Plasmid DNA Market

Viral vectors carry genetic material into cells by exploiting the molecular mechanisms by which viruses transmit their genomes to other cells for infection.It can occur in vivo or in vitro.Plasmid carriers are plasmids artificially constructed on the basis of natural plasmids to adapt to laboratory operations.In recent years, global viral vector and plasmid DNA manufacturing has developed rapidly, with a compound growth rate of about 28% during 2018-2018.In 2018, global sales of viral vector and plasmid DNA production reached $381 million.In 2018, China accounted for about 4% of global sales.In the next five years, the production of viral vectors and plasmid DNA products in China will continue to grow rapidly.Viral vector and plasmid DNA manufacturing are mainly divided into viral vector manufacturing and plasmid DNA manufacturing, among which viral vector manufacturing accounts for the largest proportion, accounting for nearly 38% of the total market in 2018.Viral vector and plasmid DNA manufacturing is mainly used for drug development and production of cancer, genetic diseases, viral infections and other diseases, among which cancer is the main application field, accounting for 35% in 2018.The market is highly competitive.Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector and Lonza are major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.Gene therapy technology innovation and clinical trials have mushroomed in recent years, and a number of gene therapy projects have been approved for marketing in the United States, the European Union, China and other countries.The target of gene therapy has also been gradually expanded from single gene genetic diseases to malignant tumors, infectious diseases, cardiovascular diseases, autoimmune diseases, metabolic diseases and other major diseases.

Viral Vector and Plasmid DNA Market contains market size and forecasts of Viral Vector and Plasmid DNA in Global, including the following market information:

Global Viral Vector and Plasmid DNA Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Viral Vector and Plasmid DNA market was valued at 686.8 million in 2021 and is projected to reach US$ 2249.6 million by 2028, at a CAGR of 18.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Plasmid DNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Viral Vector and Plasmid DNA include Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector, Lonza, BioReliance, MolMed, FUJIFILM Diosynth Biotechnologies and UniQure, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Viral Vector and Plasmid DNA companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Viral Vector and Plasmid DNA Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Viral Vector and Plasmid DNA Market Segment Percentages, by Type, 2021 (%)

Plasmid DNA

Viral Vector

Global Viral Vector and Plasmid DNA Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Viral Vector and Plasmid DNA Market Segment Percentages, by Application, 2021 (%)

Cancer

Virus Infection

Hereditary Disease

Global Viral Vector and Plasmid DNA Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Viral Vector and Plasmid DNA Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Viral Vector and Plasmid DNA revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Viral Vector and Plasmid DNA revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Brammer Bio

Oxford BioMedica

Cobra Biologics

FinVector

Lonza

BioReliance

MolMed

FUJIFILM Diosynth Biotechnologies

UniQure

Aldevron

Richter-Helm

Eurogentec

OBiO Technology

Yposkesi

Cell and Gene Therapy Catapult

MassBiologics

Biovian

VGXI

Gene Synthesis

PlasmidFactory

Jikai Gene